Fig. 1: CONSORT-like workflow description of the PDAC cohort. | British Journal of Cancer

Fig. 1: CONSORT-like workflow description of the PDAC cohort.

From: Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy

Fig. 1: CONSORT-like workflow description of the PDAC cohort.

Detailed description of the selection process of the patients and samples cohort. PDAC pancreatic ductal adenocarcinoma, IPMN intraductal papillary mucinous neoplasm, RT radiotherapy, FFX FOLFIRINOX, RT-CT conventional radiochemotherapy, SBRT stereotactic body radiotherapy, QC quality control, RNAseq RNA sequencing, No_NAT no neoadjuvant treatment group.

Back to article page